AQP11 and lung cancer: An analysis of patients treated with platinum-based chemotherapy (N = 74) showed that patients with high AQP11 mRNA expression (7%) had significantly higher overall survival then patients with LUAD expressing low levels of AQP11 Both reports suggested that, with further validation, AQP11 level might be a predictor of cisplatin resistance and overall survival in lung cancer.